Results 111 to 120 of about 2,229,162 (259)

Foundations in Wisconsin: A Directory [24th ed. 2005] [PDF]

, 2005
The 2005 release of Foundations in Wisconsin marks the 24th edition of the print directory and the 5th year of the online version (www.wifoundations.org). The directory is designed as a research tool for grantseekers interested in locating information on
Cesarz, Rebecca, Frenn, Mary C., Muthupandiyan, Megan, Thomas, Vance, Zongolowicz, Lisa   +4 more
core   +1 more source

Blinatumomab Utilization in Pediatric B‐Cell Acute Lymphoblastic Leukemia: Experience From the Mountain West

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Blinatumomab is a bispecific T‐cell engager approved for the treatment of pediatric B‐cell acute lymphoblastic leukemia (B‐ALL). Outpatient home infusion reduces hospitalization burden and optimizes resource utilization, but is logistically challenging.
Angela Parra del Riego, Kellee Parker, William C. Thomsen, James B. Ford, Mallorie B. Heneghan, David Spencer Mangum, Jennifer L. McNeer, Luke D. Maese, Claire E. F. Miller, Richard Lemons, Taumoha Ghosh   +10 more
wiley   +1 more source

Are Foundation Leaders Using Social Media? [PDF]

, 2010
All it takes is a quick visit to Glasspockets.org to see just how fast and how far foundations have come in terms of using social media. As of August 2010, the web site had documented the Web 2.0 activities of more than 650 foundations, including 271 ...

core  

Los bajos de los edificios altos: Un itinerario construido con 4 visitas puntuales

ARQ, 2006
La llegada al suelo de un edificio ayuda a constatar las implicancias de la ley de gravedad sobre el proyecto de arquitectura, y por lo mismo, su compromiso ineludible con el mundo material.
Marcelo Faiden
doaj  

Clinical and Biological Features of Response in Resistant Neuroblastoma to 131I‐Metaiodobenzylguanidine Radiotherapy in the Anti‐GD2 Immunotherapy Era

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background 131I‐metaiodobenzylguanidine (131I‐MIBG) radiotherapy is a key treatment for relapsed and refractory (R/R) neuroblastoma (NB). Patients with R/R disease treated in the modern era are increasingly exposed to anti‐GD2 immunotherapy, which exerts selective pressure and may modify both tumor cell state and microenvironment.
Benjamin J. Lerman, Katherine K. Matthay, Fabienne Hollinger, Catriona Black, Ann A. Lazar, Miguel Pampaloni, Steven G. DuBois, Kieuhoa T. Vo   +7 more
wiley   +1 more source

Building the Financial Vitality of Border Families [PDF]

, 2008
Highlights community foundations' efforts to implement the Family Economic Success anti-poverty strategies in the U.S.-Mexico border region through partnerships across sectors, benefits to the families and foundations, challenges, and ...
Carla Roberts
core  

Ethnic Differences in the Association Between SOD2 rs4880 and Hepatotoxicity in Pediatric Acute Lymphoblastic Leukemia: A Report From the REDIAL Consortium

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Treatment‐associated hepatotoxicity (TAH) is a common complication of pediatric acute lymphoblastic leukemia (ALL) treatment, but genetic risk factors remain poorly understood. We evaluated the SOD2 rs4880 variant in 544 children with ALL at Texas Children's Hospital. After adjusting for demographic and clinical covariates, the rs4880 C allele
Emily J. Mason, John P. Woodhouse, Joanna S. Yi, M. Monica Gramatges, Olga A. Taylor, Veronica A. Morales, Shalini Dhamodharan, Marley Roberts, Karen R. Rabin, Philip J. Lupo, Michael E. Scheurer, Van Huynh, Steven D. Mittelman, Etan Orgel, Austin L. Brown   +14 more
wiley   +1 more source

A Brief Guide to the Law of Mission Investing for U.S. Foundations [PDF]

, 2008
U.S foundations have considerable freedom to invest their assets in ways that further their missions, even at greater risk or lower financial return.
Anne Stetson, Mark R. Kramer
core  

Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10‐Year, Single‐Institution Experience Encompassing the COVID‐19 Pandemic

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Osteosarcoma (OS) and Ewing sarcoma (EWS) are the most common primary bone cancers in children, but acute thrombosis is poorly characterized in this population. Our study evaluated the rates of venous thromboembolism (VTE) and associated risk factors in pediatric patients with bone sarcomas treated over a 10‐year period encompassing
Sarah Kappa, Shou Xu, Mark Zobeck, Sarah E. Sartain, Nino Rainusso, Lisa Wang, Nicole Montgomery, Paige Wheaton, Sarah Whittle   +8 more
wiley   +1 more source

Foundations of Language

Studies in Applied Linguistics & TESOL, 2002
Studies in Applied Linguistics and TESOL, Vol. 2 No. 2 (2002)
openaire   +3 more sources